Takeda’s TAKHZYRO approved by EC for pediatric hereditary angioedema

Pallavi Madhiraju- November 18, 2023 0

Takeda has announced a significant advancement in the treatment of Hereditary Angioedema (HAE), with the European Commission's approval of TAKHZYRO (lanadelumab) for routine prevention in ... Read More